Progesterone [EPC]

Progesterone [EPC] was reported 23765 times

Drugs of the Progesterone [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 TEMPERATURE REGULATION DISORDER 494 0.2215
1 OVARIAN HYPERSTIMULATION SYNDROME 361 0.1547
2 AUTOIMMUNE DERMATITIS 21 0.1391
3 PROGESTERONE DECREASED 36 0.1158
4 FOOD ALLERGY 628 0.0813
5 PLACENTA ACCRETA 17 0.0783
6 FALLOPIAN TUBE DISORDER 23 0.0780
7 BLOOD OESTROGEN DECREASED 54 0.0768
8 ADNEXAL TORSION 21 0.0662
9 FOETAL DEATH 331 0.0638
10 ENDOMETRIAL THICKENING 34 0.0610
11 PREMATURE AGEING 17 0.0578
12 OVARIAN ENLARGEMENT 20 0.0521
13 POSTMENOPAUSAL HAEMORRHAGE 127 0.0487
14 CONGENITAL UMBILICAL HERNIA 17 0.0456
15 COELIAC DISEASE 447 0.0455
16 KERATOCONUS 17 0.0452
17 IMMUNODEFICIENCY 615 0.0412
18 BURSITIS 454 0.0374
19 ENDOMETRIAL HYPERPLASIA 30 0.0370
20 BUTTERFLY RASH 37 0.0365
21 ABORTION THREATENED 18 0.0361
22 PLAGIOCEPHALY 18 0.0361
23 NEONATAL ASPHYXIA 25 0.0353
24 EOSINOPHILIC PNEUMONIA ACUTE 29 0.0335
25 CYANOSIS NEONATAL 21 0.0328
26 HYPOSPADIAS 65 0.0312
27 BLOOD OESTROGEN INCREASED 18 0.0306
28 DEVELOPMENTAL HIP DYSPLASIA 24 0.0288
29 HELLP SYNDROME 17 0.0277
30 PREMATURE LABOUR 156 0.0276
31 PROGESTERONE RECEPTOR ASSAY POSITIVE 25 0.0268
32 CONGENITAL HYDRONEPHROSIS 19 0.0266
33 UTERINE POLYP 47 0.0262
34 RESPIRATORY DISORDER NEONATAL 42 0.0259
35 MENOPAUSAL SYMPTOMS 60 0.0258
36 PRESCRIBED OVERDOSE 464 0.0240
37 TWIN PREGNANCY 20 0.0238
38 HYPOPLASTIC LEFT HEART SYNDROME 16 0.0236
39 PRETERM PREMATURE RUPTURE OF MEMBRANES 28 0.0233
40 HUMAN HERPESVIRUS 6 INFECTION 44 0.0233
41 CONGENITAL ANOMALY 175 0.0226
42 OESTROGEN RECEPTOR ASSAY POSITIVE 25 0.0220
43 PULMONARY ARTERY STENOSIS CONGENITAL 16 0.0219
44 ECTOPIC PREGNANCY 65 0.0211
45 AMNIOTIC CAVITY INFECTION 15 0.0207
46 HAEMORRHAGE IN PREGNANCY 29 0.0202
47 MENOPAUSE 52 0.0202
48 PREMATURE RUPTURE OF MEMBRANES 47 0.0195
49 GESTATIONAL DIABETES 92 0.0193
50 ATRIAL SEPTAL DEFECT 151 0.0180
51 DEATH NEONATAL 25 0.0180
52 MICROCEPHALY 23 0.0179
53 HORMONE LEVEL ABNORMAL 85 0.0174
54 FOETAL HEART RATE ABNORMAL 16 0.0173
55 OLIGOHYDRAMNIOS 57 0.0171
56 NEONATAL RESPIRATORY DISTRESS 16 0.0170
57 CRYPTORCHISM 19 0.0169
58 VENTRICULAR SEPTAL DEFECT 91 0.0159
59 EXPOSURE DURING PREGNANCY 982 0.0158
60 BREAST TENDERNESS 117 0.0155
61 PRODUCT ODOUR ABNORMAL 160 0.0153
62 HEPATIC NECROSIS 57 0.0151
63 SUBCLAVIAN VEIN THROMBOSIS 17 0.0149
64 DRUG EXPOSURE BEFORE PREGNANCY 15 0.0148
65 HAEMANGIOMA 34 0.0147
66 SMALL FOR DATES BABY 71 0.0143
67 HYPOTONIA NEONATAL 22 0.0141
68 LOW BIRTH WEIGHT BABY 111 0.0140
69 INTERMENSTRUAL BLEEDING 78 0.0139
70 UPPER RESPIRATORY TRACT INFECTION 643 0.0139
71 CONTRAINDICATED PRODUCT ADMINISTERED 419 0.0138
72 PRODUCT ADHESION ISSUE 477 0.0133
73 PRE-ECLAMPSIA 62 0.0130
74 FOETAL GROWTH RESTRICTION 79 0.0130
75 RASH ERYTHEMATOUS 610 0.0127
76 PATENT DUCTUS ARTERIOSUS 50 0.0126
77 INTRA-UTERINE DEATH 20 0.0125
78 PREMATURE DELIVERY 196 0.0123
79 UTERINE HAEMORRHAGE 52 0.0122
80 PREMATURE BABY 365 0.0121
81 BREECH PRESENTATION 15 0.0119
82 MATERNAL EXPOSURE BEFORE PREGNANCY 81 0.0118
83 ABORTION MISSED 15 0.0118
84 ADNEXA UTERI PAIN 15 0.0117
85 GESTATIONAL HYPERTENSION 15 0.0116
86 NEONATAL RESPIRATORY DISTRESS SYNDROME 41 0.0116
87 PRE-EXISTING CONDITION IMPROVED 72 0.0115
88 FOETAL EXPOSURE DURING PREGNANCY 934 0.0115
89 SUSPECTED PRODUCT QUALITY ISSUE 21 0.0115
90 FLUID RETENTION 571 0.0112
91 ABORTION SPONTANEOUS 445 0.0111
92 MAST CELL ACTIVATION SYNDROME 15 0.0107
93 INFERTILITY 16 0.0106
94 PREMATURE SEPARATION OF PLACENTA 16 0.0104
95 FOETAL DISTRESS SYNDROME 22 0.0104
96 UTERINE DISORDER 24 0.0103
97 APPLICATION SITE URTICARIA 23 0.0102
98 HEPATIC ENZYME INCREASED 696 0.0102
99 ALLERGIC REACTION TO EXCIPIENT 20 0.0100
100 VAGINAL HAEMORRHAGE 430 0.0099
101 POOR QUALITY PRODUCT ADMINISTERED 104 0.0099
102 VULVOVAGINAL DISCOMFORT 43 0.0097
103 VAGINAL DISCHARGE 98 0.0097
104 TALIPES 30 0.0096
105 TERMINAL INSOMNIA 17 0.0096
106 ABORTION 28 0.0096
107 MATERNAL EXPOSURE DURING PREGNANCY 836 0.0094
108 APPLICATION SITE PRURITUS 211 0.0093
109 APPLICATION SITE RASH 127 0.0092
110 ENDOMETRIAL CANCER 20 0.0091
111 VULVOVAGINAL DRYNESS 29 0.0090
112 ADRENAL DISORDER 17 0.0088
113 BREAST ENLARGEMENT 29 0.0088
114 REACTION TO EXCIPIENT 20 0.0087
115 ABNORMAL UTERINE BLEEDING 22 0.0086
116 BREAST SWELLING 23 0.0085
117 MATERNAL EXPOSURE TIMING UNSPECIFIED 32 0.0085
118 BREAST CYST 15 0.0085
119 NORMAL NEWBORN 46 0.0085
120 BREAST CANCER FEMALE 225 0.0084
121 DECREASED IMMUNE RESPONSIVENESS 82 0.0083
122 JOINT NOISE 16 0.0081
123 BLOOD PRESSURE SYSTOLIC ABNORMAL 20 0.0081
124 PERIORBITAL OEDEMA 42 0.0081
125 LIVE BIRTH 67 0.0080
126 APPLICATION SITE IRRITATION 99 0.0079
127 UTERINE LEIOMYOMA 58 0.0079
128 NIPPLE PAIN 16 0.0079
129 SUICIDAL BEHAVIOUR 32 0.0077
130 INFUSION RELATED REACTION 502 0.0076
131 BLOOD PRESSURE DIASTOLIC INCREASED 34 0.0074
132 FINE MOTOR SKILL DYSFUNCTION 21 0.0072
133 APPLICATION SITE ERYTHEMA 190 0.0072
134 BREAST PAIN 77 0.0072
135 CHRONIC SINUSITIS 27 0.0072
136 PRODUCT ADMINISTRATION INTERRUPTED 56 0.0071
137 OVARIAN CYST 71 0.0071
138 HEAVY MENSTRUAL BLEEDING 63 0.0070
139 EOSINOPHILIC PNEUMONIA 22 0.0070
140 SPEECH DISORDER DEVELOPMENTAL 20 0.0070
141 INFUSION SITE BRUISING 15 0.0069
142 HORDEOLUM 30 0.0069
143 ENDOMETRIOSIS 33 0.0069
144 CAESAREAN SECTION 80 0.0069
145 PREGNANCY 135 0.0067
146 HOT FLUSH 508 0.0067
147 HYPERHIDROSIS 867 0.0067
148 BLOOD PRESSURE DIASTOLIC ABNORMAL 17 0.0067
149 APPLICATION SITE SWELLING 33 0.0066
150 BREAST CANCER METASTATIC 71 0.0066
151 ASTHMA 741 0.0065
152 METRORRHAGIA 111 0.0065
153 ATTENTION DEFICIT HYPERACTIVITY DISORDER 27 0.0064
154 APPLICATION SITE DISCOLOURATION 26 0.0064
155 INFUSION SITE SWELLING 40 0.0064
156 RHEUMATOID ARTHRITIS 721 0.0063
157 MATERNAL DRUGS AFFECTING FOETUS 48 0.0063
158 BRAIN FOG 97 0.0062
159 HEPATIC ENCEPHALOPATHY 57 0.0061
160 INFUSION SITE HAEMORRHAGE 20 0.0061
161 BRUXISM 32 0.0059
162 THERAPEUTIC REACTION TIME DECREASED 17 0.0058
163 AUTOIMMUNE THYROIDITIS 22 0.0058
164 EYELIDS PRURITUS 18 0.0058
165 ELECTRIC SHOCK SENSATION 16 0.0057
166 INFUSION SITE PRURITUS 18 0.0057
167 INTENTIONAL PRODUCT MISUSE 492 0.0056
168 NIGHT SWEATS 178 0.0055
169 INVASIVE DUCTAL BREAST CARCINOMA 15 0.0055
170 PRODUCT SUBSTITUTION ISSUE 306 0.0053
171 FEELING DRUNK 39 0.0052
172 JOINT SWELLING 625 0.0052
173 RHINITIS ALLERGIC 23 0.0052
174 APPLICATION SITE BURN 25 0.0051
175 PLANTAR FASCIITIS 17 0.0051
176 BLOOD THYROID STIMULATING HORMONE DECREASED 23 0.0051
177 BREAST MASS 34 0.0051
178 SNORING 19 0.0050
179 BREAST CANCER 467 0.0050
180 HYSTERECTOMY 43 0.0050
181 RETCHING 105 0.0049
182 HYPERSENSITIVITY 906 0.0049
183 SKIN ODOUR ABNORMAL 19 0.0048
184 LYME DISEASE 16 0.0048
185 CONGESTIVE CARDIOMYOPATHY 20 0.0048
186 UMBILICAL HERNIA 22 0.0047
187 INTERVERTEBRAL DISC DEGENERATION 43 0.0046
188 HEAD DISCOMFORT 82 0.0046
189 HAIR GROWTH ABNORMAL 32 0.0046
190 DEPRESSION SUICIDAL 16 0.0046
191 POLYMENORRHOEA 16 0.0046
192 HYPERACUSIS 17 0.0046
193 ONYCHOMYCOSIS 20 0.0046
194 NERVE COMPRESSION 42 0.0045
195 DEPRESSIVE SYMPTOM 16 0.0045
196 SEASONAL ALLERGY 63 0.0044
197 IRON DEFICIENCY 20 0.0044
198 DRUG INTOLERANCE 429 0.0044
199 MATERNAL EXPOSURE DURING BREAST FEEDING 18 0.0044
200 APPLICATION SITE DRYNESS 15 0.0044
201 FIBROMYALGIA 107 0.0044
202 GLUCOSE TOLERANCE IMPAIRED 26 0.0044
203 MENISCUS INJURY 27 0.0044
204 DYSMENORRHOEA 58 0.0044
205 DRUG TOLERANCE 22 0.0043
206 VULVOVAGINAL PRURITUS 22 0.0043
207 PRODUCT USE ISSUE 810 0.0043
208 RECALLED PRODUCT ADMINISTERED 41 0.0043
209 SLEEP APNOEA SYNDROME 82 0.0043
210 POOR QUALITY SLEEP 92 0.0043
211 ERYTHEMA NODOSUM 15 0.0043
212 HANGOVER 15 0.0043
213 DRUG EXPOSURE DURING PREGNANCY 145 0.0043
214 VAGINAL INFECTION 20 0.0042
215 PHOTOSENSITIVITY REACTION 70 0.0042
216 MIDDLE INSOMNIA 79 0.0042
217 PARANASAL SINUS DISCOMFORT 16 0.0042
218 SUSPECTED OFF LABEL USE 19 0.0042
219 POST-TRAUMATIC STRESS DISORDER 28 0.0042
220 APPLICATION SITE EXFOLIATION 17 0.0041
221 MIGRAINE 391 0.0041
222 VULVOVAGINAL MYCOTIC INFECTION 16 0.0041
223 NEUROLOGICAL SYMPTOM 23 0.0040
224 MENSTRUAL DISORDER 33 0.0040
225 STREPTOCOCCAL INFECTION 22 0.0039
226 PRODUCT FORMULATION ISSUE 26 0.0039
227 INFUSION SITE ERYTHEMA 33 0.0039
228 TREATMENT FAILURE 324 0.0039
229 VITAMIN D DEFICIENCY 38 0.0039
230 STRESS FRACTURE 21 0.0039
231 THINKING ABNORMAL 72 0.0039
232 SYMPTOM RECURRENCE 23 0.0038
233 ABORTION INDUCED 36 0.0038
234 THROMBOCYTOPENIA 425 0.0038
235 DEVICE ADHESION ISSUE 58 0.0038
236 DERMATITIS CONTACT 43 0.0038
237 VULVOVAGINAL BURNING SENSATION 23 0.0038
238 BLEPHARITIS 15 0.0037
239 ORAL HERPES 73 0.0037
240 STILLBIRTH 18 0.0037
241 DYSPAREUNIA 17 0.0037
242 TENDON PAIN 28 0.0037
243 NEURALGIA 89 0.0037
244 PSYCHIATRIC SYMPTOM 27 0.0037
245 TRICUSPID VALVE INCOMPETENCE 29 0.0036
246 MELANOCYTIC NAEVUS 16 0.0036
247 INFUSION SITE PAIN 47 0.0036
248 MALABSORPTION 19 0.0036
249 HEPATOTOXICITY 81 0.0036
250 HEREDITARY ANGIOEDEMA 39 0.0036
251 HYPOTHYROIDISM 116 0.0036
252 MADAROSIS 42 0.0036
253 MENINGIOMA 56 0.0036
254 MULTIPLE ALLERGIES 28 0.0036
255 TINNITUS 164 0.0036
256 CONSTIPATION 777 0.0036
257 INSURANCE ISSUE 54 0.0035
258 SPINAL OSTEOARTHRITIS 31 0.0035
259 BACK PAIN 813 0.0035
260 HEADACHE 2188 0.0035
261 PSORIASIS 453 0.0035
262 SYNOVIAL CYST 16 0.0035
263 ROSACEA 16 0.0034
264 TENDONITIS 53 0.0034
265 HYPERTENSION 725 0.0034
266 SINUSITIS 347 0.0034
267 ABDOMINAL PAIN LOWER 85 0.0034
268 RESTLESS LEGS SYNDROME 61 0.0034
269 ONYCHOCLASIS 23 0.0033
270 FOOT DEFORMITY 37 0.0033
271 VULVOVAGINAL PAIN 16 0.0033
272 PANIC ATTACK 121 0.0033
273 CYST 41 0.0033
274 PELVIC PAIN 60 0.0033
275 HEPATIC CIRRHOSIS 62 0.0033
276 DRUG-INDUCED LIVER INJURY 103 0.0033
277 ABDOMINAL DISTENSION 342 0.0033
278 CARDIAC FLUTTER 21 0.0032
279 HYPERTHYROIDISM 47 0.0032
280 MUCOUS STOOLS 16 0.0032
281 ERYTHEMA 664 0.0032
282 EYE PAIN 182 0.0032
283 APPLICATION SITE PAIN 71 0.0032
284 FOOT FRACTURE 61 0.0032
285 FEELING OF DESPAIR 15 0.0032
286 SOMNAMBULISM 21 0.0032
287 CRYING 116 0.0032
288 PARAESTHESIA ORAL 46 0.0032
289 EYE INFECTION 36 0.0032
290 MOOD SWINGS 101 0.0032
291 OSTEOPENIA 48 0.0032
292 FORMICATION 22 0.0032
293 GASTROENTERITIS VIRAL 57 0.0032
294 IMPAIRED GASTRIC EMPTYING 43 0.0032
295 DISEASE RECURRENCE 149 0.0031
296 PRODUCT PHYSICAL ISSUE 63 0.0031
297 PRODUCT COLOUR ISSUE 16 0.0031
298 MYASTHENIA GRAVIS 25 0.0031
299 SKIN WARM 18 0.0031
300 ASTHENOPIA 17 0.0031
301 INSOMNIA 813 0.0030
302 DRUG EFFECT LESS THAN EXPECTED 45 0.0030
303 LIGAMENT SPRAIN 30 0.0030
304 DRY EYE 151 0.0030
305 INTERVERTEBRAL DISC PROTRUSION 66 0.0030
306 HYPERCHOLESTEROLAEMIA 29 0.0030
307 FEELING JITTERY 57 0.0030
308 THERAPEUTIC RESPONSE UNEXPECTED 134 0.0030
309 APPLICATION SITE REACTION 21 0.0030
310 PRODUCT SIZE ISSUE 16 0.0030
311 TOOTH INFECTION 39 0.0030
312 EXOSTOSIS 27 0.0030
313 BODY TEMPERATURE DECREASED 29 0.0029
314 OCULAR DISCOMFORT 33 0.0029
315 OVARIAN CANCER 27 0.0029
316 MITRAL VALVE INCOMPETENCE 33 0.0029
317 BRADYPHRENIA 19 0.0029
318 ASCITES 85 0.0029
319 MUSCLE STRAIN 25 0.0029
320 MICTURITION URGENCY 33 0.0029
321 BLOOD IRON DECREASED 34 0.0029
322 VITREOUS FLOATERS 28 0.0028
323 PHOTOPSIA 18 0.0028
324 LIMB DISCOMFORT 88 0.0028
325 INITIAL INSOMNIA 29 0.0028
326 FOREIGN BODY SENSATION IN EYES 18 0.0028
327 HEART RATE INCREASED 279 0.0028
328 SCAR 48 0.0028
329 POOR VENOUS ACCESS 29 0.0028
330 HUNGER 39 0.0028
331 DEPRESSED MOOD 148 0.0028
332 UPPER-AIRWAY COUGH SYNDROME 23 0.0028
333 NERVE INJURY 31 0.0028
334 ANAL INCONTINENCE 25 0.0028
335 PANIC REACTION 20 0.0028
336 ERYTHEMA OF EYELID 15 0.0028
337 SKIN SWELLING 24 0.0028
338 PHARYNGEAL SWELLING 27 0.0028
339 POLYP 18 0.0027
340 PALPITATIONS 320 0.0027
341 INFUSION SITE EXTRAVASATION 17 0.0027
342 THYROID DISORDER 42 0.0027
343 NASAL DRYNESS 17 0.0027
344 ANXIETY 770 0.0027
345 INFECTION 391 0.0027
346 NECK PAIN 150 0.0027
347 MOOD ALTERED 73 0.0027
348 SINUS DISORDER 53 0.0027
349 DIVERTICULITIS 74 0.0027
350 FUNGAL INFECTION 89 0.0027
351 DISTURBANCE IN ATTENTION 144 0.0027
352 WRIST FRACTURE 32 0.0027
353 TONGUE DISORDER 19 0.0026
354 RESPIRATORY TRACT INFECTION 68 0.0026
355 NODULE 34 0.0026
356 MENORRHAGIA 51 0.0026
357 EAR INFECTION 69 0.0026
358 PRODUCT TASTE ABNORMAL 35 0.0026
359 CONCUSSION 20 0.0026
360 SCOLIOSIS 16 0.0026
361 FACIAL PAIN 23 0.0026
362 FOREIGN BODY IN REPRODUCTIVE TRACT 23 0.0026
363 ROTATOR CUFF SYNDROME 33 0.0026
364 INJECTION SITE URTICARIA 63 0.0026
365 AMENORRHOEA 45 0.0026
366 ARTHROPOD BITE 19 0.0026
367 SWELLING FACE 166 0.0025
368 OROPHARYNGEAL PAIN 236 0.0025
369 PERIPHERAL COLDNESS 35 0.0025
370 SWELLING OF EYELID 16 0.0025
371 CANDIDA INFECTION 43 0.0025
372 ABNORMAL DREAMS 70 0.0025
373 DIVERTICULUM 18 0.0025
374 MUSCLE TIGHTNESS 41 0.0025
375 GASTROOESOPHAGEAL REFLUX DISEASE 203 0.0025
376 METASTASES TO LYMPH NODES 17 0.0025
377 OVERDOSE 543 0.0025
378 CARPAL TUNNEL SYNDROME 35 0.0025
379 COVID-19 438 0.0025
380 OBSESSIVE-COMPULSIVE DISORDER 20 0.0025
381 PAIN 1527 0.0025
382 WEIGHT INCREASED 556 0.0025
383 FEELING HOT 152 0.0025
384 FEELING ABNORMAL 594 0.0025
385 JOINT STIFFNESS 65 0.0025
386 HYPERPROLACTINAEMIA 16 0.0025
387 APPLICATION SITE VESICLES 16 0.0025
388 AUTOIMMUNE DISORDER 24 0.0025
389 HERPES SIMPLEX 16 0.0025
390 DEPRESSION 560 0.0025
391 LARGE INTESTINE POLYP 17 0.0025
392 APHTHOUS ULCER 19 0.0024
393 TOOTH FRACTURE 27 0.0024
394 VERTIGO 149 0.0024
395 BLOOD PRESSURE DIASTOLIC DECREASED 18 0.0024
396 INTENTIONAL PRODUCT USE ISSUE 213 0.0024
397 PRODUCT QUALITY ISSUE 330 0.0024
398 EMBEDDED DEVICE 24 0.0024
399 TEMPERATURE INTOLERANCE 25 0.0024
400 BRONCHITIS 179 0.0024
401 BLOOD PRESSURE FLUCTUATION 58 0.0024
402 NASAL CONGESTION 142 0.0024
403 GALLBLADDER DISORDER 43 0.0024
404 FATIGUE 1872 0.0024
405 EYE IRRITATION 138 0.0024
406 KIDNEY INFECTION 47 0.0024
407 PHOTOPHOBIA 45 0.0024
408 IMPAIRED WORK ABILITY 51 0.0024
409 INTENTIONAL DOSE OMISSION 68 0.0024
410 IRON DEFICIENCY ANAEMIA 22 0.0024
411 MUSCLE SPASMS 436 0.0024
412 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 21 0.0024
413 PRODUCT ADMINISTRATION ERROR 48 0.0024
414 FEELING COLD 66 0.0024
415 EMOTIONAL DISORDER 73 0.0024
416 IMPAIRED QUALITY OF LIFE 34 0.0024
417 HEPATIC STEATOSIS 44 0.0024
418 RENAL PAIN 25 0.0024
419 RHINITIS 19 0.0024
420 SURGERY 138 0.0024
421 RASH 1025 0.0023
422 PRODUCT USE COMPLAINT 37 0.0023
423 DISCOMFORT 143 0.0023
424 EAR DISCOMFORT 24 0.0023
425 OSTEOARTHRITIS 99 0.0023
426 IRRITABLE BOWEL SYNDROME 50 0.0023
427 MUSCULOSKELETAL CHEST PAIN 36 0.0023
428 THERAPY CESSATION 119 0.0023
429 BLADDER DISORDER 23 0.0023
430 QUALITY OF LIFE DECREASED 31 0.0023
431 EYE DISCHARGE 24 0.0023
432 SLEEP DISORDER 163 0.0023
433 PYELONEPHRITIS 20 0.0023
434 TENDERNESS 24 0.0023
435 IMPAIRED DRIVING ABILITY 26 0.0023
436 IRRITABILITY 137 0.0023
437 CYSTITIS 72 0.0023
438 SENSATION OF FOREIGN BODY 19 0.0023
439 BURNING SENSATION 158 0.0023
440 DEFORMITY 21 0.0022
441 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 41 0.0022
442 NOCTURIA 27 0.0022
443 PRODUCT USE IN UNAPPROVED INDICATION 551 0.0022
444 HEART RATE DECREASED 78 0.0022
445 NERVOUSNESS 116 0.0022
446 VISUAL FIELD DEFECT 16 0.0022
447 DERMATITIS ATOPIC 116 0.0022
448 HYPERAESTHESIA 18 0.0022
449 AFFECT LABILITY 21 0.0022
450 DRY MOUTH 177 0.0022
451 GASTROINTESTINAL PAIN 24 0.0022
452 THROAT TIGHTNESS 59 0.0022
453 OFF LABEL USE 1901 0.0022
454 MUSCLE TWITCHING 50 0.0022
455 VISION BLURRED 297 0.0022
456 AFFECTIVE DISORDER 17 0.0022
457 HIATUS HERNIA 28 0.0022
458 PYREXIA 747 0.0022
459 ALOPECIA 420 0.0021
460 ORAL CANDIDIASIS 28 0.0021
461 CHROMATURIA 48 0.0021
462 ILLNESS 219 0.0021
463 HYPERBILIRUBINAEMIA 22 0.0021
464 THERAPEUTIC PRODUCT EFFECT DECREASED 95 0.0021
465 INJECTION SITE PRURITUS 142 0.0021
466 SKIN LACERATION 23 0.0021
467 VITAMIN D DECREASED 18 0.0021
468 THROAT IRRITATION 94 0.0021
469 GASTRITIS 55 0.0021
470 CHILLS 244 0.0021
471 SWOLLEN TONGUE 65 0.0021
472 SINUS CONGESTION 28 0.0021
473 HYPERTENSIVE CRISIS 23 0.0021
474 EYELID PTOSIS 21 0.0021
475 PARAESTHESIA 325 0.0021
476 INCREASED TENDENCY TO BRUISE 19 0.0021
477 BLOOD THYROID STIMULATING HORMONE INCREASED 19 0.0021
478 JOINT INJURY 44 0.0021
479 DYSGEUSIA 153 0.0021
480 BLOOD CALCIUM INCREASED 18 0.0021
481 GROIN PAIN 18 0.0020
482 SUICIDAL IDEATION 187 0.0020
483 FREQUENT BOWEL MOVEMENTS 55 0.0020
484 CEREBRAL DISORDER 15 0.0020
485 LACRIMATION INCREASED 61 0.0020
486 URTICARIA 338 0.0020
487 THIRST 36 0.0020
488 HYPERLIPIDAEMIA 24 0.0020
489 WEIGHT FLUCTUATION 21 0.0020
490 MANIA 33 0.0020
491 ANKLE FRACTURE 31 0.0020
492 DYSPEPSIA 197 0.0020
493 UTERINE CANCER 16 0.0020
494 NASOPHARYNGITIS 367 0.0020
495 HYPERSOMNIA 57 0.0020
496 SWELLING 186 0.0020
497 GASTROENTERITIS 29 0.0020
498 SOMNOLENCE 399 0.0020
499 FRUSTRATION TOLERANCE DECREASED 16 0.0020
500 FLATULENCE 112 0.0020
501 HIDRADENITIS 18 0.0020
502 DIZZINESS 983 0.0020
503 INJECTION SITE IRRITATION 25 0.0020
504 ERUCTATION 38 0.0020
505 NAUSEA 1550 0.0020
506 URINARY INCONTINENCE 58 0.0020
507 CONTUSION 188 0.0020
508 ANGER 66 0.0019
509 RESPIRATORY TRACT CONGESTION 31 0.0019
510 MYDRIASIS 25 0.0019
511 BLOOD PRESSURE SYSTOLIC INCREASED 38 0.0019
512 SPINAL OPERATION 24 0.0019
513 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 33 0.0019
514 ORAL DISCOMFORT 27 0.0019
515 PRODUCT DISTRIBUTION ISSUE 18 0.0019
516 GENERALISED OEDEMA 24 0.0019
517 ARTHRALGIA 806 0.0019
518 EYE SWELLING 72 0.0019
519 BLOOD CHOLESTEROL INCREASED 90 0.0019
520 ABDOMINAL PAIN 449 0.0019
521 VENTRICULAR EXTRASYSTOLES 20 0.0019
522 ABDOMINAL PAIN UPPER 396 0.0019
523 APHASIA 58 0.0019
524 PARANOIA 33 0.0019
525 PROCEDURAL PAIN 53 0.0019
526 BLOOD PRESSURE INCREASED 291 0.0019
527 EAR PAIN 37 0.0019
528 RHINORRHOEA 123 0.0019
529 ANKYLOSING SPONDYLITIS 25 0.0019
530 HAEMORRHOIDS 37 0.0019
531 GASTROINTESTINAL INFECTION 17 0.0019
532 INFLUENZA LIKE ILLNESS 156 0.0019
533 PRODUCT PACKAGING ISSUE 18 0.0019
534 ECZEMA 99 0.0019
535 CHOLELITHIASIS 62 0.0019
536 FLUSHING 192 0.0019
537 GINGIVAL PAIN 15 0.0019
538 WITHDRAWAL SYNDROME 79 0.0019
539 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 90 0.0019
540 DRY THROAT 19 0.0019
541 HAIR TEXTURE ABNORMAL 25 0.0019
542 LYMPHADENOPATHY 66 0.0019
543 CATARACT 111 0.0019
544 TENDON RUPTURE 23 0.0019
545 UPPER LIMB FRACTURE 37 0.0019
546 DIZZINESS POSTURAL 18 0.0019
547 EUPHORIC MOOD 19 0.0019
548 PHARYNGITIS 23 0.0019
549 DECREASED ACTIVITY 20 0.0019
550 PRESYNCOPE 45 0.0018
551 PHARYNGITIS STREPTOCOCCAL 20 0.0018
552 PRODUCT AVAILABILITY ISSUE 42 0.0018
553 INJECTION SITE DISCOLOURATION 23 0.0018
554 BACK INJURY 20 0.0018
555 CHOLECYSTECTOMY 21 0.0018
556 INCREASED APPETITE 35 0.0018
557 EATING DISORDER 39 0.0018
558 SNEEZING 41 0.0018
559 POLLAKIURIA 76 0.0018
560 OBESITY 29 0.0018
561 ADRENAL INSUFFICIENCY 22 0.0018
562 LIMB INJURY 49 0.0018
563 SALIVARY HYPERSECRETION 18 0.0018
564 OSTEOPOROSIS 74 0.0018
565 PRURITUS 689 0.0018
566 ARTHRITIS 141 0.0018
567 COGNITIVE DISORDER 83 0.0018
568 HYPOAESTHESIA 266 0.0018
569 HYPOKALAEMIA 82 0.0018
570 INJECTION SITE INDURATION 23 0.0018
571 MENTAL IMPAIRMENT 43 0.0018
572 ABDOMINAL DISCOMFORT 297 0.0018
573 FACIAL PARALYSIS 15 0.0018
574 THERAPEUTIC RESPONSE SHORTENED 58 0.0017
575 FEAR 47 0.0017
576 RASH PAPULAR 39 0.0017
577 CARDIAC MURMUR 15 0.0017
578 MUSCULAR WEAKNESS 197 0.0017
579 INJECTION SITE REACTION 119 0.0017
580 BLOOD POTASSIUM DECREASED 52 0.0017
581 CHEST DISCOMFORT 177 0.0017
582 HEART RATE IRREGULAR 39 0.0017
583 PETECHIAE 18 0.0017
584 URINARY TRACT INFECTION 294 0.0017
585 PERSONALITY CHANGE 16 0.0017
586 HYPONATRAEMIA 97 0.0017
587 PRODUCT PRESCRIBING ERROR 41 0.0017
588 APHONIA 24 0.0017
589 COMPLICATION OF DEVICE REMOVAL 31 0.0017
590 SKIN REACTION 24 0.0017
591 HYPOTONIA 17 0.0017
592 INCONTINENCE 18 0.0017
593 PSORIATIC ARTHROPATHY 69 0.0017
594 INJECTION SITE RASH 52 0.0017
595 DYSPHONIA 99 0.0017
596 OCULAR HYPERAEMIA 80 0.0017
597 LEUKOPENIA 84 0.0017
598 BEDRIDDEN 22 0.0017
599 HERPES ZOSTER 96 0.0017
600 DERMATITIS 35 0.0017
601 LOSS OF LIBIDO 15 0.0017
602 EYE PRURITUS 56 0.0017
603 AMNESIA 108 0.0017
604 BIPOLAR DISORDER 18 0.0017
605 INJECTION SITE ERYTHEMA 205 0.0017
606 APATHY 24 0.0016
607 JOINT RANGE OF MOTION DECREASED 22 0.0016
608 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 332 0.0016
609 SKIN FISSURES 32 0.0016
610 NEPHROLITHIASIS 75 0.0016
611 LETHARGY 94 0.0016
612 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 28 0.0016
613 SCIATICA 26 0.0016
614 MUSCLE SPASTICITY 20 0.0016
615 INFLUENZA 181 0.0016
616 LIP SWELLING 54 0.0016
617 PAIN IN EXTREMITY 477 0.0016
618 NIGHTMARE 56 0.0016
619 UNEVALUABLE EVENT 122 0.0016
620 JOINT DISLOCATION 17 0.0016
621 BALANCE DISORDER 139 0.0016
622 BACTERIAL INFECTION 30 0.0016
623 ORTHOSTATIC HYPOTENSION 28 0.0016
624 PARALYSIS 23 0.0016
625 PRODUCT PRESCRIBING ISSUE 35 0.0016
626 MYALGIA 273 0.0016
627 TOOTHACHE 29 0.0016
628 DRUG EFFECT DECREASED 86 0.0016
629 INJECTION SITE MASS 59 0.0016
630 MEMORY IMPAIRMENT 219 0.0016
631 TREMOR 264 0.0016
632 BODY HEIGHT DECREASED 17 0.0016
633 INFLAMMATION 82 0.0016
634 MUSCULOSKELETAL STIFFNESS 139 0.0016
635 RESTLESSNESS 58 0.0016
636 DIPLOPIA 41 0.0016
637 COORDINATION ABNORMAL 22 0.0016
638 EYE INFLAMMATION 15 0.0016
639 TOOTH ABSCESS 16 0.0016
640 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 283 0.0016
641 SLUGGISHNESS 16 0.0016
642 CELLULITIS 79 0.0016
643 VIRAL INFECTION 52 0.0016
644 DRUG PRESCRIBING ERROR 30 0.0016
645 SENSORY DISTURBANCE 25 0.0016
646 OESOPHAGITIS 17 0.0016
647 RASH PRURITIC 84 0.0015
648 CARDIOMEGALY 19 0.0015
649 GASTROINTESTINAL DISORDER 138 0.0015
650 COLD SWEAT 27 0.0015
651 INJECTION SITE DISCOMFORT 16 0.0015
652 ANOSMIA 22 0.0015
653 ECONOMIC PROBLEM 23 0.0015
654 RASH MACULAR 53 0.0015
655 CHEST PAIN 280 0.0015
656 WEIGHT DECREASED 422 0.0015
657 POST PROCEDURAL COMPLICATION 29 0.0015
658 BONE PAIN 88 0.0015
659 GAIT DISTURBANCE 286 0.0015
660 HEPATIC CYTOLYSIS 19 0.0015
661 SPEECH DISORDER 78 0.0015
662 DRUG INTERACTION 236 0.0015
663 PRODUCT DOSE OMISSION IN ERROR 42 0.0015
664 PRODUCT DOSE OMISSION ISSUE 436 0.0015
665 INCORRECT PRODUCT ADMINISTRATION DURATION 32 0.0015
666 COUGH 414 0.0015
667 DYSURIA 54 0.0015
668 DYSPHAGIA 139 0.0015
669 EYELID OEDEMA 17 0.0015
670 DEEP VEIN THROMBOSIS 95 0.0015
671 WOUND INFECTION 16 0.0015
672 ASPIRATION 16 0.0015
673 INJECTION SITE WARMTH 30 0.0015
674 INJECTION SITE NODULE 16 0.0015
675 INJECTION SITE SWELLING 111 0.0014
676 PAIN OF SKIN 39 0.0014
677 DENTAL CARIES 16 0.0014
678 COAGULOPATHY 24 0.0014
679 SKIN DISORDER 48 0.0014
680 TOOTH DISORDER 32 0.0014
681 MALAISE 631 0.0014
682 SARS-COV-2 TEST POSITIVE 19 0.0014
683 CHOKING 28 0.0014
684 ADVERSE REACTION 19 0.0014
685 DERMATITIS ALLERGIC 18 0.0014
686 CHOLECYSTITIS 17 0.0014
687 KNEE ARTHROPLASTY 30 0.0014
688 BLOOD TEST ABNORMAL 20 0.0014
689 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 78 0.0014
690 DISABILITY 28 0.0014
691 HAEMORRHAGE 148 0.0014
692 BLOOD TRIGLYCERIDES INCREASED 25 0.0014
693 BACK DISORDER 23 0.0014
694 LYMPHOCYTE COUNT DECREASED 25 0.0014
695 DRUG INEFFECTIVE 1864 0.0014
696 CONDITION AGGRAVATED 429 0.0014
697 PULMONARY MASS 21 0.0014
698 DEVICE BREAKAGE 57 0.0014
699 MULTIPLE SCLEROSIS 67 0.0014
700 GENITAL HAEMORRHAGE 18 0.0014
701 MUSCULOSKELETAL DISCOMFORT 24 0.0014
702 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 99 0.0014
703 OXYGEN SATURATION DECREASED 78 0.0014
704 CENTRAL NERVOUS SYSTEM LESION 19 0.0014
705 FEEDING DISORDER 28 0.0014
706 TASTE DISORDER 28 0.0014
707 INJECTION SITE PAIN 423 0.0014
708 INJECTION SITE BRUISING 110 0.0014
709 PULMONARY EMBOLISM 131 0.0014
710 PAIN IN JAW 39 0.0014
711 HIP ARTHROPLASTY 21 0.0014
712 IMPAIRED HEALING 45 0.0014
713 HAIR COLOUR CHANGES 17 0.0014
714 SPINAL PAIN 16 0.0014
715 PRODUCT PREPARATION ERROR 28 0.0014
716 HAEMATOCRIT DECREASED 27 0.0014
717 HEMIPARESIS 23 0.0014
718 MUSCULOSKELETAL PAIN 71 0.0014
719 CARDIOMYOPATHY 20 0.0014
720 SKIN HAEMORRHAGE 20 0.0013
721 DIARRHOEA 871 0.0013
722 CONJUNCTIVITIS 25 0.0013
723 BASAL CELL CARCINOMA 21 0.0013
724 COLITIS ULCERATIVE 60 0.0013
725 MULTIPLE ORGAN DYSFUNCTION SYNDROME 38 0.0013
726 PRODUCTIVE COUGH 64 0.0013
727 NEEDLE ISSUE 39 0.0013
728 DISORIENTATION 53 0.0013
729 DYSSTASIA 39 0.0013
730 BRONCHOSPASM 19 0.0013
731 MOUTH ULCERATION 28 0.0013
732 HYPOAESTHESIA ORAL 20 0.0013
733 EXPIRED PRODUCT ADMINISTERED 44 0.0013
734 WRONG TECHNIQUE IN DRUG USAGE PROCESS 48 0.0013
735 ROAD TRAFFIC ACCIDENT 55 0.0013
736 RIB FRACTURE 27 0.0013
737 MOVEMENT DISORDER 42 0.0013
738 PHARYNGEAL OEDEMA 20 0.0013
739 PERIPHERAL SWELLING 200 0.0013
740 HEAD INJURY 41 0.0013
741 OEDEMA PERIPHERAL 157 0.0013
742 ANAPHYLACTIC REACTION 71 0.0013
743 NEUROPATHY PERIPHERAL 122 0.0013
744 VOMITING 601 0.0013
745 EYE DISORDER 42 0.0013
746 BODY TEMPERATURE INCREASED 26 0.0013
747 LYMPHOPENIA 18 0.0013
748 MALIGNANT MELANOMA 17 0.0013
749 JAUNDICE 34 0.0013
750 MUSCLE ATROPHY 16 0.0013
751 ACTIVITIES OF DAILY LIVING IMPAIRED 25 0.0013
752 SKIN DISCOLOURATION 58 0.0013
753 MUSCULOSKELETAL DISORDER 24 0.0013
754 SEDATION 33 0.0013
755 ARTHROPATHY 70 0.0013
756 DEVICE USE ISSUE 22 0.0013
757 OEDEMA 68 0.0013
758 DYSPNOEA 708 0.0012
759 ASTHENIA 470 0.0012
760 DYSARTHRIA 47 0.0012
761 VISUAL IMPAIRMENT 154 0.0012
762 LOSS OF CONSCIOUSNESS 158 0.0012
763 DYSKINESIA 50 0.0012
764 PLATELET COUNT INCREASED 16 0.0012
765 TACHYCARDIA 109 0.0012
766 DEVICE DEFECTIVE 21 0.0012
767 ABNORMAL BEHAVIOUR 48 0.0012
768 LIVER FUNCTION TEST INCREASED 26 0.0012
769 MOBILITY DECREASED 87 0.0012
770 DEHYDRATION 161 0.0012
771 PULMONARY HYPERTENSION 25 0.0012
772 DRY SKIN 160 0.0012
773 SINUS TACHYCARDIA 17 0.0012
774 EXPOSURE VIA SKIN CONTACT 31 0.0012
775 INTESTINAL OBSTRUCTION 45 0.0012
776 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
777 PSYCHOTIC DISORDER 35 0.0012
778 STAPHYLOCOCCAL INFECTION 39 0.0012
779 DRUG DISPENSING ERROR 18 0.0012
780 ABASIA 29 0.0012
781 HYPOKINESIA 17 0.0012
782 AGEUSIA 29 0.0012
783 OSTEOMYELITIS 21 0.0012
784 BLOOD URINE PRESENT 22 0.0012
785 GASTRIC ULCER 22 0.0012
786 TRANSIENT ISCHAEMIC ATTACK 39 0.0012
787 THERAPY PARTIAL RESPONDER 18 0.0012
788 PRESCRIBED UNDERDOSE 23 0.0012
789 BONE DISORDER 21 0.0012
790 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
791 PRODUCT DISPENSING ERROR 25 0.0011
792 ACNE 87 0.0011
793 MASS 16 0.0011
794 FALL 381 0.0011
795 LOWER RESPIRATORY TRACT INFECTION 52 0.0011
796 HAEMATOCHEZIA 63 0.0011
797 BLISTER 64 0.0011
798 INCORRECT DOSE ADMINISTERED 260 0.0011
799 IMMUNE SYSTEM DISORDER 15 0.0011
800 INJURY 80 0.0011
801 HALLUCINATION, VISUAL 24 0.0011
802 SEIZURE 131 0.0011
803 FEMUR FRACTURE 35 0.0011
804 AGITATION 83 0.0011
805 ABSCESS 18 0.0011
806 MULTIPLE SCLEROSIS RELAPSE 77 0.0011
807 WHITE BLOOD CELL COUNT INCREASED 43 0.0011
808 MENSTRUATION IRREGULAR 30 0.0011
809 SKIN EXFOLIATION 94 0.0011
810 UNDERDOSE 81 0.0011
811 PROTEINURIA 21 0.0011
812 AKATHISIA 15 0.0011
813 LOWER LIMB FRACTURE 21 0.0011
814 ACUTE RESPIRATORY FAILURE 21 0.0011
815 SKIN BURNING SENSATION 78 0.0011
816 THERAPEUTIC RESPONSE DECREASED 66 0.0011
817 ANGIOEDEMA 48 0.0011
818 PSYCHOMOTOR HYPERACTIVITY 18 0.0011
819 SYNCOPE 107 0.0011
820 HYPOACUSIS 46 0.0011
821 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 76 0.0011
822 SKIN CANCER 23 0.0011
823 THERAPY NON-RESPONDER 48 0.0011
824 DEVICE ISSUE 95 0.0011
825 MENTAL DISORDER 46 0.0011
826 PLEURAL EFFUSION 64 0.0011
827 EPILEPSY 32 0.0010
828 MEDICATION ERROR 58 0.0010
829 HAEMATOMA 27 0.0010
830 PRODUCT DOSE OMISSION 68 0.0010
831 INTENTIONAL SELF-INJURY 21 0.0010
832 RESPIRATORY DISORDER 31 0.0010
833 HERNIA 20 0.0010
834 COMPLICATION ASSOCIATED WITH DEVICE 15 0.0010
835 PANCREATITIS ACUTE 23 0.0010
836 GAIT INABILITY 34 0.0010
837 PRURITUS GENERALISED 22 0.0010
838 HYPOPHAGIA 26 0.0010
839 DRUG ADMINISTRATION ERROR 31 0.0010
840 BLOOD SODIUM DECREASED 19 0.0010
841 BLOOD PRESSURE ABNORMAL 20 0.0010
842 ULCER 16 0.0010
843 DECREASED APPETITE 232 0.0010
844 THROMBOSIS 80 0.0010
845 NO ADVERSE EVENT 179 0.0010
846 CHRONIC KIDNEY DISEASE 75 0.0010
847 LABORATORY TEST ABNORMAL 29 0.0010
848 ARRHYTHMIA 46 0.0010
849 PRODUCT STORAGE ERROR 85 0.0010
850 SKIN ULCER 25 0.0010
851 RASH GENERALISED 25 0.0010
852 TOOTH LOSS 20 0.0010
853 VISUAL ACUITY REDUCED 32 0.0010
854 GASTRIC DISORDER 33 0.0010
855 SKIN IRRITATION 44 0.0010
856 INCORRECT DRUG ADMINISTRATION DURATION 27 0.0010
857 CONFUSIONAL STATE 155 0.0010
858 ANHEDONIA 25 0.0010
859 TREATMENT NONCOMPLIANCE 52 0.0009
860 FACE OEDEMA 16 0.0009
861 CIRCULATORY COLLAPSE 16 0.0009
862 LUNG DISORDER 46 0.0009
863 BLOOD PRESSURE DECREASED 62 0.0009
864 HYPERGLYCAEMIA 34 0.0009
865 INJECTION SITE HAEMORRHAGE 74 0.0009
866 BLOOD BILIRUBIN INCREASED 25 0.0009
867 PHARMACEUTICAL PRODUCT COMPLAINT 24 0.0009
868 ADVERSE DRUG REACTION 83 0.0009
869 DEAFNESS 24 0.0009
870 DRUG DOSE OMISSION 151 0.0009
871 C-REACTIVE PROTEIN INCREASED 33 0.0009
872 SPINAL FRACTURE 18 0.0009
873 COLITIS 34 0.0009
874 ILL-DEFINED DISORDER 54 0.0009
875 PULMONARY FIBROSIS 17 0.0009
876 HYPOTENSION 177 0.0009
877 SKIN LESION 24 0.0009
878 CARDIAC FAILURE 70 0.0009
879 NEOPLASM PROGRESSION 30 0.0009
880 BONE DENSITY DECREASED 27 0.0009
881 RENAL DISORDER 40 0.0009
882 DYSPNOEA EXERTIONAL 32 0.0008
883 ADVERSE EVENT 78 0.0008
884 INCORRECT DOSE ADMINISTERED BY DEVICE 22 0.0008
885 URINARY RETENTION 28 0.0008
886 HALLUCINATION 63 0.0008
887 EMOTIONAL DISTRESS 101 0.0008
888 CHOLESTASIS 16 0.0008
889 NERVOUS SYSTEM DISORDER 26 0.0008
890 SEROTONIN SYNDROME 16 0.0008
891 GLAUCOMA 16 0.0008
892 FAECES DISCOLOURED 18 0.0008
893 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 28 0.0008
894 WHEEZING 49 0.0008
895 THERAPY INTERRUPTED 59 0.0008
896 WOUND 23 0.0008
897 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24 0.0008
898 RECTAL HAEMORRHAGE 35 0.0008
899 EXTRA DOSE ADMINISTERED 33 0.0008
900 INTENTIONAL DRUG MISUSE 17 0.0008
901 TRANSAMINASES INCREASED 18 0.0008
902 ASPARTATE AMINOTRANSFERASE INCREASED 43 0.0008
903 PALLOR 22 0.0008
904 HYPOGLYCAEMIA 39 0.0008
905 TYPE 2 DIABETES MELLITUS 27 0.0008
906 HYPOXIA 28 0.0008
907 LOCALISED INFECTION 19 0.0008
908 BLINDNESS 31 0.0008
909 SYSTEMIC LUPUS ERYTHEMATOSUS 27 0.0008
910 GLOSSODYNIA 17 0.0008
911 STOMATITIS 46 0.0008
912 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35 0.0007
913 ALANINE AMINOTRANSFERASE INCREASED 46 0.0007
914 EPISTAXIS 56 0.0007
915 WHITE BLOOD CELL COUNT DECREASED 81 0.0007
916 ATRIAL FIBRILLATION 72 0.0007
917 PNEUMONIA 239 0.0007
918 AGGRESSION 36 0.0007
919 PANCREATITIS 38 0.0007
920 CONVULSION 41 0.0007
921 ANAEMIA 135 0.0007
922 HEPATITIS 18 0.0007
923 ENCEPHALOPATHY 17 0.0007
924 PERICARDIAL EFFUSION 16 0.0007
925 ACCIDENTAL EXPOSURE TO PRODUCT 71 0.0007
926 LIVER FUNCTION TEST ABNORMAL 20 0.0007
927 MENTAL STATUS CHANGES 19 0.0007
928 SUICIDE ATTEMPT 41 0.0007
929 DIABETES MELLITUS 51 0.0007
930 RED BLOOD CELL COUNT DECREASED 19 0.0007
931 PNEUMONITIS 18 0.0007
932 DRUG WITHDRAWAL SYNDROME 58 0.0007
933 RESPIRATORY DISTRESS 18 0.0007
934 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
935 HAEMOGLOBIN DECREASED 66 0.0006
936 METABOLIC ACIDOSIS 20 0.0006
937 DEVICE LEAKAGE 27 0.0006
938 BRADYCARDIA 33 0.0006
939 DEVICE DISLOCATION 27 0.0006
940 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
941 DELIRIUM 21 0.0006
942 CEREBROVASCULAR ACCIDENT 102 0.0006
943 GLYCOSYLATED HAEMOGLOBIN INCREASED 15 0.0006
944 RESPIRATORY FAILURE 43 0.0006
945 INCORRECT ROUTE OF DRUG ADMINISTRATION 21 0.0006
946 DEVICE DELIVERY SYSTEM ISSUE 16 0.0006
947 HAEMATURIA 20 0.0006
948 DEVICE MALFUNCTION 41 0.0006
949 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
950 SEPSIS 65 0.0006
951 DRUG EFFECT INCOMPLETE 21 0.0006
952 BLOOD CREATININE INCREASED 37 0.0006
953 BLOOD GLUCOSE DECREASED 27 0.0006
954 ANGINA PECTORIS 16 0.0006
955 CARDIAC DISORDER 50 0.0005
956 HEPATIC FAILURE 16 0.0005
957 LIVER DISORDER 23 0.0005
958 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
959 DEVICE DIFFICULT TO USE 34 0.0005
960 INTENTIONAL OVERDOSE 32 0.0005
961 SEPTIC SHOCK 21 0.0005
962 HOSPITALISATION 72 0.0005
963 HIP FRACTURE 15 0.0005
964 NEUTROPHIL COUNT DECREASED 19 0.0005
965 ACCIDENTAL OVERDOSE 17 0.0005
966 PLATELET COUNT DECREASED 49 0.0005
967 RENAL FAILURE ACUTE 19 0.0004
968 RENAL FAILURE 59 0.0004
969 GENERAL PHYSICAL HEALTH DETERIORATION 51 0.0004
970 ACUTE KIDNEY INJURY 67 0.0004
971 DEVICE EXPULSION 28 0.0004
972 BLOOD GLUCOSE INCREASED 81 0.0004
973 FEBRILE NEUTROPENIA 28 0.0004
974 CEREBRAL HAEMORRHAGE 15 0.0004
975 CARDIAC FAILURE CONGESTIVE 32 0.0004
976 PANCYTOPENIA 22 0.0004
977 DRUG DOSE OMISSION BY DEVICE 29 0.0004
978 MYOCARDIAL INFARCTION 62 0.0004
979 DISEASE PROGRESSION 41 0.0003
980 NEUTROPENIA 43 0.0003
981 TOXICITY TO VARIOUS AGENTS 48 0.0003
982 RENAL IMPAIRMENT 23 0.0003
983 NEOPLASM MALIGNANT 18 0.0003
984 DRUG ABUSE 17 0.0002
985 CARDIAC ARREST 16 0.0002
986 COMPLETED SUICIDE 16 0.0002
987 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
988 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
989 DEATH 103 0.0001
990 DRUG DEPENDENCE 19 0.0001